Dr. Gro Harlem Brundtland
September 23, 2000
Dear Dr. Brundtland,
I bring you a message of joy and urgency.
There is a little-known medical procedure that addresses many of the goals and projects of WHO. It is called insulin potentiation therapy (IPT).
IPT is a way for doctors to turn standard drugs into super-drugs, give them in a fraction (1/2 to 1/20) of normal dose, and reduce side effects to almost zero. IPT is a very simple procedure that doctors can learn in about a week, a slight modification in standard practice that can give astonishing, radically better results. It has been successfully used to treat a wide range of diseases, including cancer, arthritis, infectious, respiratory, cardiovascular, and neurological diseases.
In IPT a small dose of insulin is used to generate mild hypoglycemia, which is ended with glucose. This pulse of high insulin and low blood sugar has many profound effects. It boosts transport and uptake of drugs, carrying them into tissues that are otherwise poorly accessible: the brain, joints, ischemic tissue. It enhances absorption into cells. It facilitates detoxification. And it stimulates a wide range of other functions: immune system, revascularization, even stem cell growth and differentiation.
IPT is not new. It was discovered in Mexico in 1926 by Donato Perez Garcia, MD, and demonstrated in the US in the 1930s and 1940s. For historical reasons, it was never widely adopted. And, while kept alive for three generations by Dr. Perez Garcia and his son and grandson, it has been essentially ignored for 74 years. With 120 doctor-years of IPT experience in five countries, IPT is now practiced by eight doctors, in the US, Mexico, and Argentina.
Just last week, on September 18, three IPT doctors presented their best cancer cases to a panel at the US National Institutes of Health (NIH). The panel was impressed enough to call for a prospective study of IPT for cancer, which could lead to multi-center trials, and then widespread implementation. This is a big step for IPT, and I expect the next few years to bring exciting news in this domain.
But we do not have to wait for the NIH to verify IPT. They are moving slowly on cancer, and they have not yet even begun to address IPT treatment of serious diseases other than cancer. Because IPT is not a new drug or device, it can be learned and practiced by doctors right now. Any doctor can learn the fundamentals of IPT in a one-week seminar with Donato Perez Garcia MD, grandson of IPTís discoverer. Then they can try IPT and see its benefits and advantages in their own practice.
We could easily, for example, send a few forward-thinking doctors from developing countries to attend this week of training, send them home, and start to see incredible results within a month. The IPT procedure can be modified for ultra-low cost use by semi-skilled people, with a small syringe for insulin followed by oral sugar water. Fractional drug doses will make drug treatment more affordable, while giving faster, better results. Where drugs and health workers are already in place, IPT training can quickly magnify their effectiveness. As good results accumulate, we could implement worldwide IPT training and deployment.
I am seeking to form a nonprofit organization focused on getting IPT known and deployed throughout the world. This is also a chance for WHO to take a bold initiative that could have rapid, widespread, and immense benefits.
Here are some of the WHO programs that this simple protocol may address:
Dr. Brundtland, I realize that this is too many applications for some people to believe. Indeed I have had protests from some IPT doctors that talking about applications other than cancer hurts our credibility. But I am telling the truth. And I feel that it would be unethical to keep quiet about all these other applications that could so quickly help many millions or even billions of people.
I appeal to you to arrange for at least a few doctors to get the week of IPT training, so they can see results for themselves. Every doctor who has ever tried IPT has been very enthusiastic. If doctors do not try IPT, they will never see what it can do. If they DO try IPT, they should see results very quickly. And then this knowledge and method can be propagated rapidly throughout the world.
For more information about IPT, please consult my large website www.IPTQ.org. This should answer most questions. It has many IPT articles, three books, and contact information for the IPT doctors. As a supplement to this letter I am enclosing a printed copy of the home page of IPTQ.org, and my curriculum vitae.
I look forward to hearing from you, and the other people of WHO, about this matter Ė your reactions, thoughts, and suggestions. I would love to collaborate with WHO on this project. I would love to meet with you or anyone to discuss this matter and to plan implementation. Please let me know how I can be of further assistance.